SCHEMBL3202677

SCHEMBL3202677

CCOc1ccc(N(Cc2cncnc2)c2ccc(C(=O)OC(C)(C)C)cc2)cc1OCC

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPK1 P28482 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
S1PR1 P21453 2/20 0.35
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 1/20 0.34
RXRA P19793 2/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
LTC4S Q16873 1/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
PGGT1B P53609 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3126412 0.95 TSHR (0.42) HDAC6L3MBTL1ALDH1A1MAPK1KMT2A
SCHEMBL3212923 0.95 MAPK1 (0.39) HDAC6L3MBTL1ALDH1A1MAPK1KMT2A
SCHEMBL3203192 0.93 RXRA (0.42) HDAC6ALDH1A1MAPK1RXRARXRB
SCHEMBL3120590 0.92 LMNA (0.38) HDAC6MAPK1KMT2ARAB9ANPSR1
SCHEMBL3131869 0.86 TSHR (0.46) L3MBTL1TSHRLMNARXRARXRB
SCHEMBL3201995 0.85 HRH4 (0.39) HDAC6ALDH1A1MAPK1KMT2ANPC1
SCHEMBL3192199 0.85 HRH4 (0.39) HDAC6L3MBTL1ALDH1A1MAPK1KMT2A
SCHEMBL3205217 0.85 RXRA (0.40) HDAC6RAB9ARXRALTC4S
SCHEMBL3129630 0.85 MAPT (0.44) L3MBTL1ALDH1A1MAPK1KMT2ANPC1
SCHEMBL3120270 0.84 PDE4A (0.38) HDAC6KMT2ALMNARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B HDAC6 329/4885L3MBTL1 3388/4885ALDH1A1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.